Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
29 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/29/3141800/20739/en/Ultragenyx-to-Participate-at-Investor-Conferences-in-September.html
21 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/21/3137576/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
18 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/18/3134959/20739/en/Ultragenyx-Initiates-Rolling-Submission-of-Biologics-License-Application-BLA-to-U-S-FDA-for-DTX401-AAV-Gene-Therapy-for-the-Treatment-of-Glycogen-Storage-Disease-Type-Ia-GSDIa.html
05 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/05/3127792/20739/en/Ultragenyx-Reports-Second-Quarter-2025-Financial-Results-and-Corporate-Update.html
31 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/31/3125396/20739/en/Ultragenyx-Completes-Enrollment-of-Phase-3-Aspire-Study-Evaluating-GTX-102-for-the-Treatment-of-Angelman-Syndrome.html
30 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/30/3124055/20739/en/Ultragenyx-to-Host-Conference-Call-for-Second-Quarter-2025-Financial-Results-and-Corporate-Update.html
ABOUT THIS PAGE
Ultragenyx Pharmaceutical is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Triheptanoin bulk with DMF offered by Ultragenyx Pharmaceutical